GSK-FFU111439

Study Sponsor: GSK

Study Title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily Intranasal Administration of Fluticasone Furoate Nasal Spray 110mcg in Adult and Adolescent Subjects 12 years of Age and Older with Perennial Allergic Rhinitis (PAR)

Medicine or Vaccine (generic name)

fluticasone furoate

Sponsor Identification Number

FFU111439

Trial Registry Identification Number(#'s)

NCT00609674 2007-006562-15

Medical Condition

Rhinitis, Allergic, Perennial

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=FFU111439

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT00609674

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2007-006562-15

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2013